Follow on Google News News By Tag * PK/PD * Pharmacometrics * Pharmacokinetics * Drug-disease Modeling * Market Modeling * Physiological Modeling * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar SeriesYou are invited to attend Dr. Goburru’s webinar The “Learn & Apply” Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00). This talk will summarize applying drug-disease-trial modeling to decision-making in drug development.
By: Rosa & Co, LLC “PK/PD and physiologic M&S techniques have been established commercial disciplines for more than a decade,” said Dr. Ron Beaver, Rosa’s Founder and CEO. “However, the ultimate potential for these techniques to speed development, improve efficacy, and reduce costs is far from being realized. Our webinar series is designed to extend the ability of both providers and consumers of drug-disease M&S to recognize when and how these techniques can be harnessed in real-world applications throughout a product’s lifecycle.” This webinar series will primarily focus on M&S of drug action, disease progression, and trial populations and outcomes. From time to time, special webinars will focus on related M&S topics of interest in product development; “Dr. Gobburu’s talk will provide valuable insights into the latest achievements of M&S in bringing much needed medicines to patients faster. As the head of the Division of Pharmacometrics at FDA, he is well placed to have a broad view of M&S activities in pharmaceutical companies and regulatory decision-making processes.” said Dr. Toufigh Gordi, the Coordinator of the “Impact” series and President of Rosa’s PK/PD and Clinical Pharmacology Services. Register for this free webinar at http://www.rosaandco.com/ About Rosa Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/ # # # Rosa creates robust mathematical models that simulate drug effects and trial outcomes. Modeling and Simulation complement traditional experimental methods, enabling unique insights that streamline drug development and regulatory interactions. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|